Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 127 citing Clark: Therapeutic plasma exchange: an update from the Canadian Apheresis Group. (0.09 sec) 

Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing …

- hematologylibrary.org
M Furlan, R Robles, M Solenthaler, M … - Blood, 1997 - bloodjournal.hematologylibrary.org
In patients with thrombotic thrombocytopenic purpura (TTP), excessive
intravascular platelet aggregation has been associated with appearance in plasma
of unusually large von Willebrand factor (vWF ) multimers. These extremely ...
Cited by 316 - Related articles - BL Direct - All 8 versions

How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

- hematologylibrary.org
JN George - Blood, 2000 - bloodjournal.hematologylibrary.org
Adults who have the defining diagnostic features of TTP (Table 1) but in whom
acute renal failure is a prominent abnormality, with or without a diarrhea
prodrome, have been described as having adult HUS, and some consider this ...
Cited by 297 - Related articles - BL Direct - All 12 versions

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: …

- bloodjournal.org
SK Vesely, JN George, B Lammle, JD Studt, L … - Blood, 2003 - Am Soc Hematology
Thrombotic thrombocytopenic purpura (TTP) was fatal in 90% of patients prior to
the availability of effective treatment with plasma exchange. 1 Observations of
the presenting features and clinical course of TTP suggested a pentad of ...
Cited by 274 - Related articles - BL Direct - All 8 versions

Partial amino acid sequence of purified von Willebrand factor-cleaving protease

- bloodjournal.org
HE Gerritsen, R Robles, B Lammle, M Furlan - Blood, 2001 - Am Soc Hematology
Plasma infusion or exchange is considered to be the therapy of choice in
patients with TTP. Until the early 1960s, less than 3% of patients with TTP
survived. 22 During the next decades, the treatment of TTP with plasma ...
Cited by 264 - Related articles - BL Direct - All 4 versions

Waldenström's macroglobulinemia

- hematologylibrary.org [PDF] 
MA Dimopoulos, A Anagnostopoulos - Best Practice & Research Clinical Haematology, 2005 - Elsevier
The diagnosis of Waldenström's macroglobulinemia (WM) requires evidence of
bone-marrow infiltration by lymphoplasmacytoid lymphoma and detection of serum
monoclonal protein of IgM type. The normal counterpart of the WM malignant ...
Cited by 219 - Related articles - BL Direct - All 30 versions

Transfusion medicine: looking to the future

- saude.gov.br [PDF] 
LT Goodnough, A Shander, ME Brecher - The Lancet, 2003 - Elsevier
The evolution of transfusion medicine into a clinically oriented discipline
emphasising patient care has been accompanied by challenges that need to be
faced as specialists look to the future. Emerging issues that affect blood ...
Cited by 184 - Related articles - All 8 versions

Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic …

- jcojournal.org
S Imashuku, K Kuriyama, T Teramura, E Ishii, … - Journal of Clinical Oncology, 2001 - jcojournal.org
From the Kyoto City Institute of Health and Environmental Sciences; Department
of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto; Division of
Pediatrics, Hamanomachi Hospital, Fukuoka; Division of Hematology, Chiba ...
Cited by 114 - Related articles - BL Direct - All 8 versions

Hemolytic uremic syndrome

- asnjournals.org
M Noris, G Remuzzi - Journal of the American Society of Nephrology, 2005 - Am Soc Nephrol
Non–Shiga toxin-associated HUS (non–Stx-HUS) comprises a heterogeneous group
of patients in whom an infection by Stx-producing bacteria could be excluded as
cause of the disease. It can be sporadic or familial (ie, more than one ...
Cited by 116 - Related articles - All 5 versions

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, …

- bloodjournal.org
J Caprioli, M Noris, S Brioschi, G Pianetti, F … - Blood, 2006 - Am Soc Hematology
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy with
manifestations of hemolytic anemia, thrombocytopenia, and renal impairment.
Genetic studies have shown that mutations in complement regulatory proteins ...
Cited by 104 - Related articles - BL Direct - All 7 versions

Complications of plasma exchange in 71 consecutive patients treated for clinically …


MA Rizvi, SK Vesely, JN George, L Chandler, … - Transfusion, 2000 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 78 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google